Protagenic Therapeutics, Inc. (PTIX)
1.026
-0.03
(-3.22%)
USD |
OTCM |
Sep 08, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.857M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -64.00% |
| Valuation | |
| PE Ratio | 0.3479 |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | 1.078 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 99.91% |
Profile
| Protagenic Therapeutics, Inc. operates as a biotechnology company. The firm engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. It offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY. |
| URL | http://www.protagenic.com |
| Investor Relations URL | N/A |
| HQ State/Province | New York |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap Value |
| Next Earnings Release | N/A |
| Last Earnings Release | Feb. 27, 2014 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 05, 2005 |
Profile
| Protagenic Therapeutics, Inc. operates as a biotechnology company. The firm engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. It offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY. |
| URL | http://www.protagenic.com |
| Investor Relations URL | N/A |
| HQ State/Province | New York |
| Sector | Health Care |
| Industry | Biotechnology |
| Equity Style | Small Cap Value |
| Next Earnings Release | N/A |
| Last Earnings Release | Feb. 27, 2014 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 05, 2005 |